MX339306B - Agente anti-fungico. - Google Patents
Agente anti-fungico.Info
- Publication number
- MX339306B MX339306B MX2014003563A MX2014003563A MX339306B MX 339306 B MX339306 B MX 339306B MX 2014003563 A MX2014003563 A MX 2014003563A MX 2014003563 A MX2014003563 A MX 2014003563A MX 339306 B MX339306 B MX 339306B
- Authority
- MX
- Mexico
- Prior art keywords
- scytalidium
- fungal agent
- genus
- fungi belonging
- lanoconazole
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Urology & Nephrology (AREA)
- Dermatology (AREA)
- Ophthalmology & Optometry (AREA)
- Communicable Diseases (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Oncology (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Un agente anti-fúngico contra un hongo del género Scytalidium (Scytalidium dimidiatum, Scytalidium hyalinum etc.), preferiblemente un agente anti-fúngico para micosis superficial causada por un hongo del género Scytalidium como hongo patógeno, que contiene luliconazol o una sal farmacéuticamente aceptable del mismo y/o lanoconazol o una sal farmacéuticamente aceptable del mismo como ingrediente(s) activo(s).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2011209903 | 2011-09-26 | ||
PCT/JP2012/074580 WO2013047530A1 (ja) | 2011-09-26 | 2012-09-25 | 抗真菌剤 |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2014003563A MX2014003563A (es) | 2014-11-26 |
MX339306B true MX339306B (es) | 2016-05-18 |
Family
ID=47995562
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2014003563A MX339306B (es) | 2011-09-26 | 2012-09-25 | Agente anti-fungico. |
Country Status (8)
Country | Link |
---|---|
US (1) | US9040573B2 (es) |
EP (1) | EP2762139B1 (es) |
JP (1) | JP5349716B2 (es) |
CN (1) | CN103957907B (es) |
BR (1) | BR112014007177A2 (es) |
ES (1) | ES2580480T3 (es) |
MX (1) | MX339306B (es) |
WO (1) | WO2013047530A1 (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20160279101A1 (en) * | 2013-11-19 | 2016-09-29 | Pola Pharma Inc. | Pharmaceutical composition for treatment of pneumonia associated with fusarium fungus |
CN106170285A (zh) * | 2014-04-07 | 2016-11-30 | 日本农药株式会社 | 包含抗真菌剂和甾类化合物的药物组合物 |
ITUB20155902A1 (it) | 2015-11-25 | 2017-05-25 | Nathura S P A | Composizione farmaceutica cicatrizzante per uso topico |
CN105541813B (zh) * | 2016-02-29 | 2019-05-10 | 浙江东亚药业股份有限公司 | 一种咪唑乙腈衍生物酸式盐及其制备方法和应用 |
CN107865825B (zh) * | 2016-09-28 | 2022-05-20 | 四川海思科制药有限公司 | 一种卢立康唑外用喷雾剂药物组合物及其制备方法 |
CN112957319A (zh) * | 2021-02-05 | 2021-06-15 | 王京海 | 一种抗真菌液及其制备方法和应用 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6293227A (ja) | 1985-10-19 | 1987-04-28 | Nippon Nohyaku Co Ltd | 抗真菌剤 |
JP3278738B2 (ja) | 1995-07-08 | 2002-04-30 | 日本農薬株式会社 | 抗真菌剤 |
CA2645110C (en) * | 2006-03-08 | 2013-11-19 | Nihon Nohyaku Co., Ltd. | Pharmaceutical composition for external use |
WO2009028495A1 (ja) | 2007-08-27 | 2009-03-05 | Nihon Nohyaku Co., Ltd. | 真菌性皮膚炎用剤 |
JP2011209903A (ja) | 2010-03-29 | 2011-10-20 | Sony Corp | 命令フェッチ装置、プロセッサ、プログラム変換装置、および、プログラム変換方法 |
-
2012
- 2012-09-25 MX MX2014003563A patent/MX339306B/es active IP Right Grant
- 2012-09-25 CN CN201280046574.1A patent/CN103957907B/zh active Active
- 2012-09-25 EP EP12836654.9A patent/EP2762139B1/en not_active Not-in-force
- 2012-09-25 WO PCT/JP2012/074580 patent/WO2013047530A1/ja active Application Filing
- 2012-09-25 ES ES12836654.9T patent/ES2580480T3/es active Active
- 2012-09-25 US US13/995,820 patent/US9040573B2/en active Active
- 2012-09-25 BR BR112014007177A patent/BR112014007177A2/pt not_active Application Discontinuation
- 2012-09-25 JP JP2013526221A patent/JP5349716B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
MX2014003563A (es) | 2014-11-26 |
EP2762139A4 (en) | 2015-03-18 |
EP2762139B1 (en) | 2016-04-13 |
ES2580480T3 (es) | 2016-08-24 |
CN103957907B (zh) | 2016-03-30 |
EP2762139A1 (en) | 2014-08-06 |
CN103957907A (zh) | 2014-07-30 |
JP5349716B2 (ja) | 2013-11-20 |
US20140142154A1 (en) | 2014-05-22 |
US9040573B2 (en) | 2015-05-26 |
WO2013047530A1 (ja) | 2013-04-04 |
BR112014007177A2 (pt) | 2017-04-04 |
JPWO2013047530A1 (ja) | 2015-03-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NL301201I2 (nl) | Asciminib of een farmaceutisch aanvaardbaar zout daarvan, zoals asciminibhydrochloride | |
NO2020012I1 (no) | Osilodrostat eller et farmasøytisk akseptabelt salt derav, inkludert osilodrostat dihydrogenfosfat | |
MX2013012542A (es) | Compuestos de amida y aplicacion farmaceutica para el mismo. | |
PL2808325T3 (pl) | Podstawione azole, przeciwwirusowy składnik czynny, kompozycja farmaceutyczna, sposób ich wytwarzania i stosowania | |
EA201201263A1 (ru) | Фармацевтическая композиция, содержащая этексилат дабигатрана | |
MX350447B (es) | Composicion farmaceutica de disolucion rapida. | |
PH12015500900A1 (en) | A stabilized pemetrexed formulation | |
MX367286B (es) | Composiciones de dexmedetomidina intranasal y sus metodos de uso. | |
MX339306B (es) | Agente anti-fungico. | |
PH12015502178A1 (en) | Pyridinylpyrazoloquinoline compound | |
IT1404931B1 (it) | Composizioni oftalmiche per la somministrazione di principi attivi liposolubili . | |
TW201144301A (en) | Processes for preparing linezolid | |
EA201391212A1 (ru) | Новые применения хлорида холина в агрохимических препаратах | |
MY168212A (en) | A new therapeutical composition containing apomorphine as active ingredient | |
PH12016500865A1 (en) | Composite formulation comprising tadalafil and amlodipine | |
JO3112B1 (ar) | تركيبة دوائية سريعة التحلل | |
NZ627473A (en) | Aryloxyacetamide compound and pesticide | |
IN2014DN10669A (es) | ||
UA109804C2 (xx) | 2-метоксипіридин-4-ільні похідні | |
GT201400108A (es) | Tableta orodispersable de sildenafil y método para preparar la misma | |
WO2013081563A3 (en) | Stable voglibose tablet formulations | |
PH12019501027A1 (en) | Therapeutic drug or prophylactic drug for diabetic nephropathy | |
RU2012143852A (ru) | Средство для купирования алкогольного абстинентного синдрома | |
UY34135A (es) | Método para combatir hongos fitopatógenos en plantas o semillas para proteger contra el ataque fúngico con 2,3,5,6-tetraciano-[1,4]ditiína | |
Oladele | The Emergence of Social Networks on the Web as New Marketing Tools |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |